A vaccine that is capable of delivering a double whammy against AIDS-causing human immunodeficiency virus by both providing immunity against the infection while at the same time destroying cells infected by the virus is ready for clinical trials, a group of Russian researchers announced.

The vaccine is an artificial virus-like particle whose outer casing consists of the TBI (T- and B cell epitopes containing immunogen) protein constructed by the researchers combined with the polyglucin protein.

The scientists emphasize that as the combiHIVvac vaccine not only stimulates antibody production but also destroys the cells infected by the virus, this vaccine can be considered not only a prophylactic one but also as a therapeutic one.

The vaccine they developed is ready for clinical trials.

Read the entire release here.